Ευρωπαϊκή Ένωση - Ισλανδικά - EMA (European Medicines Agency)

bristol myers squibb pharma eeig - fedratinib dihydrochloride monohydrate - myeloproliferative disorders; primary myelofibrosis - Æxlishemjandi lyf - inrebic is indicated for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis who are janus associated kinase (jak) inhibitor naïve or have been treated with ruxolitinib.

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 90 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

williams & halls ehf. - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 30 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - cinacalcetum hýdróklóríð - filmuhúðuð tafla - 60 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

bluefish pharmaceuticals ab - escitalopramum oxalat - filmuhúðuð tafla - 5 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

orion corporation - perphenazinum inn - húðuð tafla - 2 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - darunavir propylene glycolate - filmuhúðuð tafla - 600 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

medical valley invest ab - venlafaxinum hýdróklóríð - forðatafla - 150 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

teva b.v.* - bupropionum hýdróklóríð - tafla með breyttan losunarhraða - 300 mg

Ισλανδία - Ισλανδικά - LYFJASTOFNUN (Icelandic Medicines Agency)

viatris limited - atropine sulfate - stungulyf, lausn - 0,5 mg/ml